How employers can help break mental health stigma in the workplace with precision technology
Shawn Patrick O'Brien
Chairman & CEO, Genomind
As Chief Executive Officer, Mr. O’Brien is responsible for setting the strategy and delivering on the full financial potential of Genomind.Prior to Genomind, O’Brien founded and served as chair of Key BioPharma Partners, LLC, a private biopharma consulting firm. He also served as president and CEO of Cipher Pharmaceuticals Inc., AltheRx Pharmaceuticals Inc., Profectus BioSciences Inc. and Solstice NeuroSciences Inc., in addition to his multiple senior global leadership roles within AstraZeneca.O’Brien is board chair for Alto Pharma, a privately held company, and serves on the advisory boards of Greater Philadelphia Life Sciences Congress, and the Hubert J.P. Schoemaker Classic.
Jennifer Morelli is Senior Vice President of Events & Experiences at Audacy, home to the industry’s most influential collection of broadcast and digital content, podcasts, and premium live experiences.In her role, Jennifer leads the company’s experiential sponsorship business development strategy spanning across live events, over the air content features, music initiatives, artist experiences and company-driven initiatives. Jennifer especially enjoys working directly with clients in developing custom solutions designed to meet their marketing challenges and understands the key to success is maximizing the brand-to-fan connection through meaningful, authentic, creative integrations that enhance the consumer experience. She collaborates closely with the company programming & internal media teams to curate the ultimate event or marketing program that provides a mutually benefiting result for the brand partner & Audacy.
Senior Medical Science Liaison & Lead Scientist for Product Development, Genomind
Dr. VanDorn earned his Doctor of Pharmacy degree from Temple University School of Pharmacy while concurrently optimizing novel stem-cell disease models and genetic assay technology at the Children’s Hospital of Philadelphia, work that has been published in several peer-reviewed journals. He has served in a wide range of health care settings including the Armed Forces, Clinical and Hospital Pharmacy, and medical missions in developing countries. These experiences cultivated a keen understanding of both the technological and clinical aspects of genetic testing. This serves him well as Senior Medical Science Liaison and Lead Scientist for Product Development at Genomind, where he facilitates research and development of the Genomind platform and provides counsel and education to clinicians and patients on the interpretation of genetic assay results.
Join thousands of health plan executives, providers, investors, employers, technologists, and other digital health enthusiasts as we support BEAM advance emotional and mental health access for underserved populations.